Deprivation of human pluripotent stem cell-derived trpv1+, mrgprx1+ and scn9a+ sensory neurons and their functional characterization
AssigneeThe Johns Hopkins University
InventorsGabsang LEE, Xinzhong DONG, Zhuolun Poppy WANG
Life of this patent
Estimating the term…
Abstract
Provided herein are methods of producing a population of pluripotent stem cell-derived sensory neurons (PSC-SNs) expressing a target gene associated with pain. In addition, provided herein are compositions and methods comprising populations of pluripotent stems cells for treating pain, osteoarthritis, and osteoarthritis related conditions.
Claims20
An isolated population of cells comprising pluripotent stem cell-derived sensory neurons (PSC-SNs) or descendants thereof, the PSC-SNs expressing one or more of a sensory neuron marker and a pan neuronal marker.
A method, comprising:
- administering pluripotent stem cell-derived sensory neurons (PSC-SNs) to a subject, the PSC-SNs expressing one or more of a sensory neuron marker and a pan neuronal marker.
A composition for base editing target gene mutations, comprising:
- a base editor;
- and
- a guide RNA (gRNA),
- the base editor and the gRNA targeting at least one gene, the at least one gene comprising SCN9A, TRPV1, MRGPRX1, or KCNQ2.
Dependencies are inferred from the claim text.